| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
8.69(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.6 - $17.6 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 12.5 |
| Insider 6 Months : 12.5 |
| Insider 3/6 Months : 25 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
53,100 |
53,100 |
53,100 |
152,300 |
| Total Buy Value |
$872,502 |
$872,502 |
$872,502 |
$2,216,881 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
4 |
4 |
4 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kinard David S |
See Remarks |
• – – |
2020-02-14 |
4 |
D |
$30.98 |
$126,708 |
D/D |
(4,090) |
62,127 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
14,308 |
66,217 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2020-02-14 |
4 |
D |
$30.98 |
$90,245 |
D/D |
(2,913) |
54,872 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,192 |
57,785 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2020-02-14 |
4 |
D |
$30.98 |
$157,843 |
D/D |
(5,095) |
61,159 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
17,887 |
66,254 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2020-02-14 |
4 |
D |
$30.98 |
$79,185 |
D/D |
(2,556) |
36,411 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
8,942 |
38,967 |
|
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2020-02-01 |
4 |
D |
$30.90 |
$876,139 |
D/D |
(28,354) |
397,925 |
|
- |
|
| Lin Sarena S |
See Remarks |
• – – |
2020-02-01 |
4 |
D |
$30.90 |
$129,255 |
D/D |
(4,183) |
57,630 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2019-12-31 |
4 |
D |
$29.45 |
$31,394 |
D/D |
(1,066) |
48,367 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2019-12-31 |
4 |
D |
$29.45 |
$143,952 |
D/D |
(4,888) |
51,909 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2019-12-31 |
4 |
D |
$29.45 |
$81,135 |
D/D |
(2,755) |
30,025 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2019-12-31 |
4 |
D |
$29.45 |
$81,135 |
D/D |
(2,755) |
47,593 |
|
- |
|
| Simmons Jeffrey N |
Presiident, CEO & Director |
• • – |
2019-12-31 |
4 |
D |
$29.45 |
$1,287,760 |
D/D |
(43,727) |
426,279 |
|
- |
|
| Young Todd S. |
See Remarks |
• – – |
2019-12-03 |
4 |
D |
$27.30 |
$35,053 |
D/D |
(1,284) |
27,599 |
|
- |
|
| Bilbrey John P |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,233 |
8,016 |
|
- |
|
| Garcia Art A |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,236 |
7,055 |
|
- |
|
| Hoover R David |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,496 |
21,075 |
|
- |
|
| Mcdonald Kirk P |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,233 |
8,016 |
|
- |
|
| Kurzius Lawrence Erik |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,496 |
21,075 |
|
- |
|
| Anand Kapila K |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,496 |
12,275 |
|
- |
|
| Harrington Michael J |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,496 |
12,779 |
|
- |
|
| Pollard-Knight Denise |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,233 |
8,016 |
|
- |
|
| Kochevar Deborah Turner |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,233 |
9,016 |
|
- |
|
390 Records found
|
|
Page 13 of 16 |
|
|
0.08 (0.45%) 
